Global data is sending mixed signals, with improving PMIs in Europe and parts of Asia, ongoing energy cost pressures, and higher bond yields and tariffs shaping returns across markets. In this setting, many investors are focusing on companies where management has significant skin in the game and where growth expectations from analysts and leadership align. That is exactly what the Fast Growing Stocks With High Insider Ownership screener aims to capture, highlighting businesses where insiders are heavily invested in the outcome. This article reveals three stocks from that screener that may merit a closer look for growth focused portfolios.
Tesla (TSLA)
Overview: Tesla is a global manufacturer of electric vehicles and battery based energy products, selling cars, solar solutions and storage systems directly to consumers, businesses and utilities, while also offering services like charging, insurance and software upgrades.
Market Cap: US$1.3t
Tesla attracts attention because it sits at the crossroads of electric vehicles, energy storage and AI, yet its fundamentals send a mixed message that growth focused investors cannot ignore. Forecast earnings growth of 34.8% a year and solid revenue growth expectations sit alongside current profit margins of 3.7% that have come under pressure as spending on robotaxis, Optimus robotics and AI infrastructure pushes free cash flow into the red. The stock trades at a rich valuation on sales compared with auto peers, while return on equity is forecast to remain in the low double digits. For investors, the key consideration is whether Tesla’s heavy investment in autonomy, energy storage and in house AI chips will justify today’s premium or leave expectations running ahead of reality.
Tesla’s push into autonomy and in house AI chips could be the real story behind its premium valuation, but the trade off between 34.8% forecast earnings growth and profit pressure is not obvious from the headline numbers. Start with the analyst forecasts for Tesla to see what might be hiding in plain sight.
Orla Mining (TSX:OLA)
Overview: Orla Mining is a Vancouver based gold producer and developer that acquires, explores and operates precious metal projects, with key assets spanning Mexico, Panama, the United States and Canada.
Operations: Orla Mining generates revenue primarily from Musselwhite Mine at about US$817.2 million, Camino Rojo at about US$348.3 million, and corporate activities of about US$130.6 million.
Market Cap: CA$4.9b
Orla Mining is noted for pairing rapid earnings growth with a growing portfolio of producing and development assets, while still trading well below some estimates of its intrinsic value. The ramp up of Musselwhite and the planned combination with Equinox Gold point to a larger, more diversified producer, and recent Q2 production numbers show the assets are already contributing meaningfully. At the same time, investors need to weigh permitting and operational risks at projects such as Camino Rojo, as well as past shareholder dilution and higher all in sustaining cost guidance. For growth focused portfolios, a key consideration is whether the market is fully pricing in Orla’s margin potential and the implications of the Equinox deal for future scale and resilience.
Orla Mining’s growth story and merger plans are grabbing attention, but the real question is whether the market is misreading its potential and project risks, so walk through the full picture with the 3 key rewards and 1 important warning sign
Hinge Health (HNGE)
Overview: Hinge Health provides a digital musculoskeletal care platform that combines app based physical therapy, AI powered motion tracking and connected wearables to help employees manage injuries, chronic pain and post surgical recovery. It sells this technology enabled care primarily to self insured employers and health plans that are looking to cut costs while improving member outcomes.
Operations: Hinge Health currently generates about US$646.3 million in revenue from its Healthcare Software platform.
Market Cap: US$5.9b
Hinge Health stands out because it is turning a fast growing musculoskeletal care platform into a profitable, software like business while still being priced well below some estimates of fair value. Revenue grew 49.8% over the past year and the company is already generating a 31% free cash flow margin, helped by AI tools that allowed it to serve 47% more members in 2025 without lifting care team costs. At the same time, it remains exposed to employer benefits budgets, high executive pay and competition from larger digital health and AI players, so execution on engagement and new programs such as Medicare Advantage and HingeSelect matters. The key question for investors is whether Hinge Health’s data advantage and margin profile justify its premium P/S multiple and the spread between its current price and analyst targets.
Hinge Health’s 31% free cash flow margin and software style model suggest the story is bigger than revenue alone, so review the analyst forecasts for Hinge Health to see what the current price might be missing.
The three stocks in this article are only a starting point, as the full Fast Growing Stocks With High Insider Ownership screener surfaced 1,278 more companies with optimistic analyst and management outlooks that could have equally compelling narratives through the Fast Growing Stocks With High Insider Ownership screener. Use Simply Wall St to identify, filter and analyze the specific catalysts and insider backed growth stories that fit your highest conviction ideas, allowing you to focus on the opportunities that matter most.
Take Control of Your Investment Journey
If Hinge Health or any of these companies have caught your attention, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value and track any new developments as they happen. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.
Seeking Fresh Alternatives Before Others Do
Fresh stock ideas can attract attention quickly once momentum builds and prices start moving, so use these focused shortlists while the data is still relevant.
- Spot companies where strong balance sheets support current momentum by scanning the curated list of solid balance sheet and fundamentals (49 results) before they move out of your preferred valuation range.
- Target potential income workhorses with resilient payouts by reviewing the hand picked 9 dividend fortresses while yields still look appealing.
- Explore opportunities related to infrastructure demand by focusing on the targeted 35 power grid technology and infrastructure stocks while these under the radar plays are still emerging on institutional screens.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com